1256062

Ralph A DeFronzo, MD — FEI 3002812722

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
December 6, 2024
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
San Antonio, TX (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
755221 CFR 312.66Changes in research
756021 CFR 312.60FD-1572, protocol compliance
756221 CFR 312.60Informed consent